685 related articles for article (PubMed ID: 12428810)
1. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.
Chan SL; Furukawa K; Mattson MP
Neuromolecular Med; 2002; 2(2):167-96. PubMed ID: 12428810
[TBL] [Abstract][Full Text] [Related]
2. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease.
Mattson MP; Gary DS; Chan SL; Duan W
Biochem Soc Symp; 2001; (67):151-62. PubMed ID: 11447832
[TBL] [Abstract][Full Text] [Related]
3. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
4. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
[TBL] [Abstract][Full Text] [Related]
5. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
6. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.
Czech C; Tremp G; Pradier L
Prog Neurobiol; 2000 Mar; 60(4):363-84. PubMed ID: 10670705
[TBL] [Abstract][Full Text] [Related]
7. Neuronal and glial calcium signaling in Alzheimer's disease.
Mattson MP; Chan SL
Cell Calcium; 2003; 34(4-5):385-97. PubMed ID: 12909083
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
9. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.
Suh YH; Checler F
Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532
[TBL] [Abstract][Full Text] [Related]
10. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
[TBL] [Abstract][Full Text] [Related]
11. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.
Turner PR; O'Connor K; Tate WP; Abraham WC
Prog Neurobiol; 2003 May; 70(1):1-32. PubMed ID: 12927332
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
Kulnane LS; Lamb BT
Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
[TBL] [Abstract][Full Text] [Related]
13. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
14. Presenilin-1 mutations associated with familial Alzheimer's disease do not disrupt protein transport from the endoplasmic reticulum to the Golgi apparatus.
Tan Y; Hong J; Doan T; McConlogue L; Maltese WA
Biochim Biophys Acta; 1998 Jul; 1407(1):69-78. PubMed ID: 9639678
[TBL] [Abstract][Full Text] [Related]
15. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.
Dickey CA; Loring JF; Montgomery J; Gordon MN; Eastman PS; Morgan D
J Neurosci; 2003 Jun; 23(12):5219-26. PubMed ID: 12832546
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
17. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
18. The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.
Klevanski M; Herrmann U; Weyer SW; Fol R; Cartier N; Wolfer DP; Caldwell JH; Korte M; Müller UC
J Neurosci; 2015 Dec; 35(49):16018-33. PubMed ID: 26658856
[TBL] [Abstract][Full Text] [Related]
19. Presenilin and APP Regulate Synaptic Kainate Receptors.
Barthet G; Moreira-de-Sá A; Zhang P; Deforges S; Castanheira J; Gorlewicz A; Mulle C
J Neurosci; 2022 Dec; 42(49):9253-9262. PubMed ID: 36288945
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
